Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease

被引:100
|
作者
Kalender, B
Ozdemir, AC
Koroglu, G
机构
[1] Kocaeli Univ, Fac Med, Div Nephrol, Kocaeli, Turkey
[2] Kocaeli Univ, Fac Med, Div Psychiat, Kocaeli, Turkey
来源
NEPHRON CLINICAL PRACTICE | 2006年 / 102卷 / 3-4期
关键词
depression; C-reactive protein; hypoalbuminemia; chronic kidney disease; end-stage renal disease;
D O I
10.1159/000089669
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Depression, which is the most common psychological disorder among patients with end-stage renal disease ( ESRD), is commonly associated with poor oral intake which can aggravate anemia and malnutrition in chronic dialysis patients. The objective of this study is to explore the association between depression and C-reactive protein (CRP), ferritin, serum albumin and hemoglobin/ hematocrit in patients with chronic kidney disease (CKD) and ESRD. Methods: Sixty-eight patients on hemodialysis (HD), 47 patients on continuous ambulatory peritoneal dialysis ( CAPD) and 26 patients with CKD on conservative management were enrolled in this study. All patients were evaluated for the presence of depression using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Axis I Disorders-Clinician Version (SCID-CV). The severity of depression was evaluated by means of the Beck Depression Inventory ( BDI). Serum CRP ( nephelometric method), ferritin (immunometric method), albumin (bromcresol green technique), hemoglobin, and hematocrit levels were measured. Results: A total of 34 of 141 patients (24.1%) had depression. The mean BDI score was higher in depressive patients compared to nondepressive patients. In HD patients the frequency of depression and CRP and ferritin levels were higher than in other groups. Patients with depression had lower hemoglobin, hematocrit and serum albumin levels and higher CRP and ferritin levels than patients without depression. The BDI score showed a positive correlation with serum CRP and ferritin levels, but a negative correlation with the serum albumin level. Conclusions: We observed that CKD and ESRD patients with anemia, hypoalbuminemia and higher serum CRP and ferritin concentrations should be evaluated for depression after potential somatic causes have been eliminated. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:C115 / C121
页数:7
相关论文
共 50 条
  • [21] Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management
    Shirazian, Shayan
    Grant, Candace D.
    Aina, Olufemi
    Mattana, Joseph
    Khorassani, Farah
    Ricardo, Ana C.
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (01): : 94 - 107
  • [22] Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease
    Tsai, Yi-Chun
    Hung, Chi-Chih
    Hwang, Shang-Jyh
    Wang, Shu-Li
    Hsiao, Shih-Ming
    Lin, Ming-Yen
    Kung, Lan-Fang
    Hsiao, Pei-Ni
    Chen, Hung-Chun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (05) : 1621 - 1626
  • [23] Depression among patients with end-stage renal disease in hemodialysis
    Silva Junior, Geraldo B.
    Daher, Elizabeth F.
    Buosi, Ana Paula A.
    Lima, Rafael S. A.
    Lima, Mikaelly M.
    Silva, Eveline C.
    Sampaio, Aline M.
    Santana, Joao Moises L.
    Monteiro, Francisco Emmanuel C.
    Araujo, Snia M. H. A.
    PSYCHOLOGY HEALTH & MEDICINE, 2014, 19 (05) : 547 - 551
  • [24] Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease
    Lin, Ming-Yen
    Chiu, Yi-Wen
    Chang, Jung-San
    Lin, Hung-Lung
    Lee, Charles Tzu-Chi
    Chiu, Guei-Fen
    Kuo, Mei-Chuan
    Wu, Ming-Tsang
    Chen, Hung-Chun
    Hwang, Shang-Jyh
    KIDNEY INTERNATIONAL, 2015, 88 (06) : 1365 - 1373
  • [25] Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease
    Ramesh, Mayur S.
    Yee, Jerry
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (01) : 30 - 34
  • [26] Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.
    Miller P.D.
    Current Osteoporosis Reports, 2005, 3 (1) : 5 - 12
  • [27] Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease
    Nakhoul, Georges N.
    Huang, Haiquan
    Arrigain, Susana
    Jolly, Stacey E.
    Schold, Jesse D.
    Nally, Joseph V., Jr.
    Navaneethan, Sankar D.
    AMERICAN JOURNAL OF NEPHROLOGY, 2015, 41 (06) : 456 - 463
  • [28] Care of the critically ill patient with advanced chronic kidney disease or end-stage renal disease
    Hotchkiss, John R.
    Palevsky, Paul M.
    CURRENT OPINION IN CRITICAL CARE, 2012, 18 (06) : 599 - 606
  • [29] Inflammatory markers in chronic kidney disease and end stage renal disease patients
    Zakaria, Mahmoud M.
    Derbala, Safaa A.
    Salem, Ayman E.
    EL-Agroudy, Amgad E.
    El-Tantawy, Fatma M.
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (10) : 6857 - 6862
  • [30] Effects of spironolactone on cardiovascular outcomes in chronic kidney disease and end-stage renal disease patients
    Sun, Li-Jing
    Xu, Bo
    Chen, Shun-Jie
    Liu, Shuang
    He, Bin
    Jiang, Geng-Ru
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 794 - 803